Risk of Highly Pathogenic Avian Influenza A/H5N1 Virus in Pediatrics

Area of Science:

• Virology
• Public Health
• Epidemiology

Background:

• Highly Pathogenic Avian Influenza A/H5N1 virus (HPAI A/H5N1) has been detected across multiple US states starting in 2024.
• While the current risk of human infection remains low, the evolving nature of the virus presents potential challenges.

Purpose of the Study:

• To highlight the elevated risk of severe HPAI A/H5N1 infection in children.
• To advocate for the prioritization of pediatric populations in preventive strategies against HPAI A/H5N1.

Main Methods:

• This study is a review of current HPAI A/H5N1 surveillance data and risk assessments.
• Analysis of HPAI A/H5N1 epidemiological trends and their implications for public health.

Main Results:

• Children represent a vulnerable demographic for severe outcomes from HPAI A/H5N1 infection.
• The continuous evolution of HPAI A/H5N1 underscores the need for proactive public health measures.

Conclusions:

• Preventive strategies must prioritize children, including their inclusion in vaccine and therapeutic clinical trials.
• Vaccine implementation plans should specifically address the needs of pediatric populations to mitigate HPAI A/H5N1 risks.